Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F el Massioui

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
L'Encephale|December 1, 1991
[Evaluation by evoked potentials of attentional abilities in patients with depression under amoxapine or imipramine]F el Massioui
Behavioural Neurology|February 4, 2014
Event-related potentials in Parkinson's disease: a reviewE Růžička, F El Massioui
Electroencephalography and Clinical Neurophysiology|July 1, 1988
Attention impairment and psychomotor retardation in depressed patients: an event-related potential studyF el Massioui, N Lesèvre
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|April 1, 1995
Temporal localization of the response selection processing stageJ L Nandrino, F el Massioui
Neurophysiologie Clinique = Clinical Neurophysiology|January 1, 1995
[Study of the organization of sensorimotor stages in man using delayed evoked potentials]J L Nandrino, F el Massioui
Neurophysiologie Clinique = Clinical Neurophysiology|June 1, 1988
[Electrophysiological study of attention mechanisms in depressed patients with characteristics of psychomotor retardation]F el Massioui, R Grob, N Lesevre
Neuropsychologia|March 1, 1993
Time for reorienting of attention: a premotor hypothesis of the underlying mechanismM A Bédard, F el Massioui, B Pillon, et al.
Neuroreport|November 4, 1996
Attention deficits in depression: an electrophysiological markerF el Massioui, J Everett, M T Martin, et al.
Sbornik Lekarsky|February 28, 2001
The effects of apomorphine on attentional processing in Parkinson's diseaseE Růzicka, F el Massioui, B Pillon, et al.
Clinical Neuropharmacology|May 14, 1998
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonistM A Bédard, F el Massioui, C Malapani, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
L'Encephale|December 1, 1991
[Evaluation by evoked potentials of attentional abilities in patients with depression under amoxapine or imipramine]F el Massioui
Behavioural Neurology|February 4, 2014
Event-related potentials in Parkinson's disease: a reviewE Růžička, F El Massioui
Electroencephalography and Clinical Neurophysiology|July 1, 1988
Attention impairment and psychomotor retardation in depressed patients: an event-related potential studyF el Massioui, N Lesèvre
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|April 1, 1995
Temporal localization of the response selection processing stageJ L Nandrino, F el Massioui
Neurophysiologie Clinique = Clinical Neurophysiology|January 1, 1995
[Study of the organization of sensorimotor stages in man using delayed evoked potentials]J L Nandrino, F el Massioui
Neurophysiologie Clinique = Clinical Neurophysiology|June 1, 1988
[Electrophysiological study of attention mechanisms in depressed patients with characteristics of psychomotor retardation]F el Massioui, R Grob, N Lesevre
Neuropsychologia|March 1, 1993
Time for reorienting of attention: a premotor hypothesis of the underlying mechanismM A Bédard, F el Massioui, B Pillon, et al.
Neuroreport|November 4, 1996
Attention deficits in depression: an electrophysiological markerF el Massioui, J Everett, M T Martin, et al.
Sbornik Lekarsky|February 28, 2001
The effects of apomorphine on attentional processing in Parkinson's diseaseE Růzicka, F el Massioui, B Pillon, et al.
Clinical Neuropharmacology|May 14, 1998
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonistM A Bédard, F el Massioui, C Malapani, et al.
Pageof 2